AT195252T - Drug delivery device with controlled release - Google Patents

Drug delivery device with controlled release

Info

Publication number
AT195252T
AT195252T AT94810212T AT94810212T AT195252T AT 195252 T AT195252 T AT 195252T AT 94810212 T AT94810212 T AT 94810212T AT 94810212 T AT94810212 T AT 94810212T AT 195252 T AT195252 T AT 195252T
Authority
AT
Austria
Prior art keywords
delivery device
drug delivery
controlled release
release
controlled
Prior art date
Application number
AT94810212T
Other languages
German (de)
Inventor
Louis Savastano
James Carr
Elizabeth Quadros
Shailesh Shah
Satish Chandra Khanna
Original Assignee
Novartis Erfind Verwalt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US5243593A priority Critical
Priority to US16543793A priority
Application filed by Novartis Erfind Verwalt Gmbh filed Critical Novartis Erfind Verwalt Gmbh
Publication of AT195252T publication Critical patent/AT195252T/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
AT94810212T 1993-04-23 1994-04-14 Drug delivery device with controlled release AT195252T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US5243593A true 1993-04-23 1993-04-23
US16543793A true 1993-12-10 1993-12-10

Publications (1)

Publication Number Publication Date
AT195252T true AT195252T (en) 2000-08-15

Family

ID=26730596

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94810212T AT195252T (en) 1993-04-23 1994-04-14 Drug delivery device with controlled release

Country Status (14)

Country Link
US (1) US5681584A (en)
EP (1) EP0621032B1 (en)
JP (2) JP3943144B2 (en)
AT (1) AT195252T (en)
AU (1) AU687784B2 (en)
CA (1) CA2121870C (en)
CY (1) CY2252B1 (en)
DE (2) DE69425453D1 (en)
DK (1) DK0621032T3 (en)
ES (1) ES2149250T3 (en)
GR (1) GR3034571T3 (en)
IL (1) IL109338A (en)
NZ (1) NZ260365A (en)
PT (1) PT621032E (en)

Families Citing this family (182)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK281042B6 (en) * 1992-09-18 2000-11-07 Yamanouchi Pharmaceutical Co., Ltd Sustained-release hydrogel preparation
AT195252T (en) * 1993-04-23 2000-08-15 Novartis Erfind Verwalt Gmbh Drug delivery device with controlled release
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
DE4332394A1 (en) * 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonide pellets with controlled release profile and methods for their preparation
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5500227A (en) * 1993-11-23 1996-03-19 Euro-Celtique, S.A. Immediate release tablet cores of insoluble drugs having sustained-release coating
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US6210714B1 (en) 1993-11-23 2001-04-03 Euro-Celtique S.A. Immediate release tablet cores of acetaminophen having sustained-release coating
GB9412394D0 (en) 1994-06-21 1994-08-10 Danbiosyst Uk Colonic drug delivery composition
JPH0940561A (en) * 1995-08-02 1997-02-10 Fujitsukusu Kk Purgative agent
DE69720055T2 (en) * 1996-08-16 2003-09-11 Alza Corp Administration form for the delivery of rising doses of active ingredient
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US5788987A (en) 1997-01-29 1998-08-04 Poli Industria Chimica Spa Methods for treating early morning pathologies
BRPI9802144B1 (en) * 1997-05-30 2017-03-28 Ezequiel Mayorga Jorge improved multilayer osmotic device
JP2001515855A (en) 1997-09-09 2001-09-25 アルザ・コーポレーション Using the drug coating composition
DK1035834T3 (en) * 1997-12-05 2002-07-08 Alza Corp Osmotic dosage form comprising a first and second coating
US6598603B1 (en) * 1997-12-31 2003-07-29 Astra Aktiebolag Method for treating respiratory diseases
US8524277B2 (en) 1998-03-06 2013-09-03 Alza Corporation Extended release dosage form
US6224907B1 (en) * 1998-03-06 2001-05-01 Alza Corporation Anti-asthma therapy
US6245357B1 (en) * 1998-03-06 2001-06-12 Alza Corporation Extended release dosage form
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
US6551613B1 (en) * 1998-09-08 2003-04-22 Alza Corporation Dosage form comprising therapeutic formulation
EP1121104B1 (en) * 1998-10-01 2005-01-12 Novartis AG New controlled release oral formulations for rivastigmine
DE19845358A1 (en) * 1998-10-02 2000-04-06 Roehm Gmbh Coated dosage forms controlled release
JP2000119181A (en) * 1998-10-06 2000-04-25 Kureha Chem Ind Co Ltd Release controlling oral pharmaceutical preparation of esculetin and its derivative
TW577756B (en) * 1998-10-23 2004-03-01 Pfizer Res & Dev Controlled-release pharmaceutical formulations
US6033686A (en) * 1998-10-30 2000-03-07 Pharma Pass Llc Controlled release tablet of bupropion hydrochloride
US6096341A (en) * 1998-10-30 2000-08-01 Pharma Pass Llc Delayed release tablet of bupropion hydrochloride
WO2007037790A2 (en) * 2005-06-08 2007-04-05 Elan Corporation, Plc Modified release famciclovir compositions
US20090149479A1 (en) * 1998-11-02 2009-06-11 Elan Pharma International Limited Dosing regimen
AT411011T (en) * 1998-11-02 2008-10-15 Elan Pharma Int Ltd Multiparticulate composition of methylphenidate with modified release
US20060240105A1 (en) * 1998-11-02 2006-10-26 Elan Corporation, Plc Multiparticulate modified release composition
US20070122481A1 (en) * 1998-11-02 2007-05-31 Elan Corporation Plc Modified Release Compositions Comprising a Fluorocytidine Derivative for the Treatment of Cancer
US20090297597A1 (en) * 1998-11-02 2009-12-03 Gary Liversidge Modified Release Ticlopidine Compositions
AU1738800A (en) 1998-11-23 2000-06-13 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
USRE43799E1 (en) 1999-06-14 2012-11-13 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
EP1183014B1 (en) * 1999-06-14 2003-10-08 Cosmo S.p.A. Controlled release and taste masking oral pharmaceutical compositions
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
US6251432B1 (en) * 1999-07-01 2001-06-26 Abbott Laboratories Sustained release dosage form unit having latex coating and method of making the same
US6458383B2 (en) * 1999-08-17 2002-10-01 Lipocine, Inc. Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
GB9923045D0 (en) * 1999-09-29 1999-12-01 Novartis Ag New oral formulations
AU764453B2 (en) 1999-10-29 2003-08-21 Euro-Celtique S.A. Controlled release hydrocodone formulations
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
WO2001034204A1 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
US6936275B2 (en) * 1999-12-20 2005-08-30 Scolr, Inc. Amino acid modulated extended release dosage form
BR0016707A (en) 1999-12-23 2002-09-03 Pfizer Prod Inc drug dosage form layered powered by hydrogel
AU783685B2 (en) * 1999-12-23 2005-11-24 Pfizer Products Inc. Hydrogel-driven drug dosage form
US9579091B2 (en) 2000-01-05 2017-02-28 Integrated Vascular Systems, Inc. Closure system and methods of use
US7842068B2 (en) 2000-12-07 2010-11-30 Integrated Vascular Systems, Inc. Apparatus and methods for providing tactile feedback while delivering a closure device
US8758400B2 (en) 2000-01-05 2014-06-24 Integrated Vascular Systems, Inc. Closure system and methods of use
US6391048B1 (en) 2000-01-05 2002-05-21 Integrated Vascular Systems, Inc. Integrated vascular device with puncture site closure component and sealant and methods of use
US6461364B1 (en) 2000-01-05 2002-10-08 Integrated Vascular Systems, Inc. Vascular sheath with bioabsorbable puncture site closure apparatus and methods of use
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
US6491949B2 (en) * 2000-01-14 2002-12-10 Osmotica Corp. Osmotic device within an osmotic device
AR026148A1 (en) * 2000-01-21 2003-01-29 Osmotica Argentina S A Osmotic device preformed passageway that increases in size
US7220430B2 (en) * 2000-01-27 2007-05-22 Tanabe Seiyaku Co., Ltd. Sustained-release preparation and process for producing the same
US6420473B1 (en) * 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
US7223421B2 (en) * 2000-06-30 2007-05-29 Mcneil-Ppc, Inc. Teste masked pharmaceutical particles
US6500457B1 (en) 2000-08-14 2002-12-31 Peirce Management, Llc Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
EP1294288B1 (en) 2000-09-08 2011-03-30 Abbott Vascular Inc. Surgical staple
US6626918B1 (en) 2000-10-06 2003-09-30 Medical Technology Group Apparatus and methods for positioning a vascular sheath
KR100960200B1 (en) 2000-10-30 2010-05-27 유로-셀티크 소시에떼 아노뉨 Controlled release hydrocodone formulations
CA2359812C (en) * 2000-11-20 2004-02-10 The Procter & Gamble Company Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US8690910B2 (en) 2000-12-07 2014-04-08 Integrated Vascular Systems, Inc. Closure device and methods for making and using them
US6623510B2 (en) 2000-12-07 2003-09-23 Integrated Vascular Systems, Inc. Closure device and methods for making and using them
US7211101B2 (en) 2000-12-07 2007-05-01 Abbott Vascular Devices Methods for manufacturing a clip and clip
US20020119196A1 (en) * 2000-12-21 2002-08-29 Narendra Parikh Texture masked particles containing an active ingredient
SE0100200D0 (en) * 2001-01-24 2001-01-24 Astrazeneca Ab New film coating
JP2004522016A (en) * 2001-03-22 2004-07-22 マイズ テック カンパニー リミテッド Sewage backflow and Odor device is attached to the drains of the road
US20030070584A1 (en) 2001-05-15 2003-04-17 Cynthia Gulian Dip coating compositions containing cellulose ethers
US6838093B2 (en) * 2001-06-01 2005-01-04 Shire Laboratories, Inc. System for osmotic delivery of pharmaceutically active agents
IES20010547A2 (en) 2001-06-07 2002-12-11 Christy Cummins Surgical Staple
AU2002320360B2 (en) * 2001-07-10 2005-05-26 Teva Pharmaceutical Industries Ltd. Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
GB0120835D0 (en) * 2001-08-28 2001-10-17 Smithkline Beecham Plc Process
US7122143B2 (en) * 2001-09-28 2006-10-17 Mcneil-Ppc, Inc. Methods for manufacturing dosage forms
US7323192B2 (en) * 2001-09-28 2008-01-29 Mcneil-Ppc, Inc. Immediate release tablet
EP1429724B1 (en) 2001-09-28 2013-11-06 McNeil-PPC, Inc. Dosage form containing a confectionery composition
US7217381B2 (en) * 2001-09-28 2007-05-15 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US6982094B2 (en) 2001-09-28 2006-01-03 Mcneil-Ppc, Inc. Systems, methods and apparatuses for manufacturing dosage forms
US6837696B2 (en) * 2001-09-28 2005-01-04 Mcneil-Ppc, Inc. Apparatus for manufacturing dosage forms
US7838026B2 (en) 2001-09-28 2010-11-23 Mcneil-Ppc, Inc. Burst-release polymer composition and dosage forms comprising the same
US8309118B2 (en) 2001-09-28 2012-11-13 Mcneil-Ppc, Inc. Film forming compositions containing sucralose
US7807197B2 (en) * 2002-09-28 2010-10-05 Mcneil-Ppc, Inc. Composite dosage forms having an inlaid portion
US9308220B2 (en) 2001-12-11 2016-04-12 Cosmo Technologies Limited Pharmaceutical compositions for the oral administration of heparin or derivatives thereof
ITMI20012599A1 (en) * 2001-12-11 2003-06-11 Cosmo Spa Pharmaceutical compositions for oral administration of heparin osuoi derivatives, useful for the therapy of inflammatory diseases Home Switch
RU2323717C2 (en) 2001-12-19 2008-05-10 Астразенека Аб Novel film coating
GB0203296D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel composition
US6749621B2 (en) 2002-02-21 2004-06-15 Integrated Vascular Systems, Inc. Sheath apparatus and methods for delivering a closure device
WO2003086353A1 (en) * 2002-04-05 2003-10-23 Penwest Pharmaceuticals Co. Sustained release metoprolol formulations
AU2003269744A1 (en) * 2002-05-15 2003-12-02 Sun Pharmaceutical Industries Limited Oral osmotic controlled drug delivery system
AU2003238642A1 (en) 2002-06-04 2003-12-19 Christy Cummins Blood vessel closure clip and delivery device
US20050232995A1 (en) 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
US20040126358A1 (en) * 2002-09-16 2004-07-01 Warne Nicholas W. Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8084058B2 (en) 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) * 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US20080220074A1 (en) * 2002-10-04 2008-09-11 Elan Corporation Plc Gamma radiation sterilized nanoparticulate docetaxel compositions and methods of making same
CA2504038A1 (en) * 2002-10-31 2004-05-21 Alza Corporation Dosage form providing ascending release of liquid formulation
US20040097484A1 (en) * 2002-11-14 2004-05-20 Marc Cantillion Once a day galantamine pharmaceutical compositions and methods of use
US20070077301A1 (en) * 2002-12-23 2007-04-05 Meyer Glenn A Venlafaxine osmotic device formulation
US8398656B2 (en) 2003-01-30 2013-03-19 Integrated Vascular Systems, Inc. Clip applier and methods of use
US7905900B2 (en) 2003-01-30 2011-03-15 Integrated Vascular Systems, Inc. Clip applier and methods of use
US8202293B2 (en) 2003-01-30 2012-06-19 Integrated Vascular Systems, Inc. Clip applier and methods of use
US8029822B2 (en) * 2003-05-22 2011-10-04 Osmotica Kereskedelmi és Seolgáltató KFT Rupturing controlled release device having a preformed passageway
US20060177507A1 (en) * 2003-05-22 2006-08-10 Joaquina Faour Controlled release device containing lercanidipine
CN1816324A (en) * 2003-07-04 2006-08-09 尼克麦德丹麦公司 Parathyroid hormone (pth) containing pharmaceutical compositions for oral use
US7314640B2 (en) * 2003-07-11 2008-01-01 Mongkol Sriwongjanya Formulation and process for drug loaded cores
JP2005075826A (en) * 2003-08-29 2005-03-24 Boehringer Ingelheim Internatl Gmbh Controlled release preparation comprising porous silica support
US7737133B2 (en) * 2003-09-03 2010-06-15 Agi Therapeutics Ltd. Formulations and methods of treating inflammatory bowel disease
US7825106B2 (en) * 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
JP5666075B2 (en) 2003-09-19 2015-02-12 サン・ファーマシューティカル・インダストリーズ・リミテッドSun Pharmaceutical Industries Limited Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US20050074514A1 (en) * 2003-10-02 2005-04-07 Anderson Oliver B. Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms
US7498018B2 (en) * 2003-10-03 2009-03-03 Bracco Diagnostics Inc. Contrast media for use in medical and diagnostic procedures and methods of using the same
US20050129764A1 (en) * 2003-12-11 2005-06-16 Vergez Juan A. Osmotic device containing licofelone
CA2551528A1 (en) * 2003-12-31 2005-07-21 Genzyme Corporation Enteric coated aliphatic amine polymer bile acid sequestrants
US20050215561A1 (en) * 2004-03-19 2005-09-29 Krishnendu Ghosh Pharmaceutical dosage forms and compositions
US7404970B2 (en) * 2004-04-13 2008-07-29 Konec, Inc. Pain relief composition, method to form same, and method to use same
IES20040368A2 (en) 2004-05-25 2005-11-30 James E Coleman
LT2801354T (en) * 2004-10-08 2017-06-26 Forward Pharma A/S Controlled release pharmaceutical compositions comprising a fumaric acid ester
US20080020041A1 (en) * 2004-10-19 2008-01-24 Ayres James W Enteric Coated Compositions that Release Active Ingredient(s) in Gastric Fluid and Intestinal Fluid
US8586085B2 (en) * 2004-11-08 2013-11-19 Biokey, Inc. Methods and formulations for making pharmaceutical compositions containing bupropion
US20060099262A1 (en) * 2004-11-08 2006-05-11 Biokey, Inc. Methods and formulations for making controlled release oral dosage form
WO2006063078A2 (en) * 2004-12-08 2006-06-15 Elan Corporation, Plc Topiramate pharmaceuticals composition
KR100670798B1 (en) 2004-12-17 2007-01-17 한국전자통신연구원 Database cache system
US20070298098A1 (en) * 2005-02-16 2007-12-27 Elan Pharma International Limited Controlled Release Compositions Comprising Levetiracetam
US8673352B2 (en) 2005-04-15 2014-03-18 Mcneil-Ppc, Inc. Modified release dosage form
US8926633B2 (en) 2005-06-24 2015-01-06 Abbott Laboratories Apparatus and method for delivering a closure element
US8313497B2 (en) 2005-07-01 2012-11-20 Abbott Laboratories Clip applier and methods of use
US20070031496A1 (en) * 2005-08-04 2007-02-08 Edgren David E Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
US20070053983A1 (en) * 2005-09-06 2007-03-08 Girish Jain Extended release compositions of metoprolol succinate
CA2635313C (en) 2005-12-29 2013-12-31 Osmotica Corp. Triple combination release multi-layered tablet
US20070231390A1 (en) * 2006-03-29 2007-10-04 Andrx Labs, Llc Formulations including hygroscopic compounds
US8808310B2 (en) 2006-04-20 2014-08-19 Integrated Vascular Systems, Inc. Resettable clip applier and reset tools
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
NZ573173A (en) * 2006-06-01 2012-03-30 Msd Consumer Care Inc Phenylephrine pharmaceutical formulation and compositions for colonic absorption
US8556930B2 (en) 2006-06-28 2013-10-15 Abbott Laboratories Vessel closure device
US8758398B2 (en) 2006-09-08 2014-06-24 Integrated Vascular Systems, Inc. Apparatus and method for delivering a closure element
US20080260823A1 (en) * 2007-04-20 2008-10-23 Sciele Pharma, Inc. Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
US8637080B2 (en) * 2007-06-28 2014-01-28 Osmotica Kereskedelmi és Szolgáltató, KFT Rupturing controlled release device comprising a subcoat
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
US8893947B2 (en) 2007-12-17 2014-11-25 Abbott Laboratories Clip applier and methods of use
US20090157101A1 (en) 2007-12-17 2009-06-18 Abbott Laboratories Tissue closure system and methods of use
US7841502B2 (en) 2007-12-18 2010-11-30 Abbott Laboratories Modular clip applier
CA2715584A1 (en) * 2008-02-15 2009-10-08 Sun Pharma Advanced Research Company Ltd. Oral controlled release tablet
GB0808537D0 (en) * 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
US9282965B2 (en) 2008-05-16 2016-03-15 Abbott Laboratories Apparatus and methods for engaging tissue
US8398676B2 (en) 2008-10-30 2013-03-19 Abbott Vascular Inc. Closure device
US8858594B2 (en) 2008-12-22 2014-10-14 Abbott Laboratories Curved closure device
US8323312B2 (en) 2008-12-22 2012-12-04 Abbott Laboratories Closure device
US20100173882A1 (en) 2009-01-08 2010-07-08 Lipocine, Inc. Steroidal Compositions
CN109044985A (en) 2009-01-09 2018-12-21 前进制药知识产权有限公司 Pharmaceutical preparation comprising one of corrosion skeleton or a variety of fumarates
US9486191B2 (en) 2009-01-09 2016-11-08 Abbott Vascular, Inc. Closure devices
US20100179589A1 (en) 2009-01-09 2010-07-15 Abbott Vascular Inc. Rapidly eroding anchor
US9414820B2 (en) 2009-01-09 2016-08-16 Abbott Vascular Inc. Closure devices, systems, and methods
US9173644B2 (en) 2009-01-09 2015-11-03 Abbott Vascular Inc. Closure devices, systems, and methods
US9089311B2 (en) 2009-01-09 2015-07-28 Abbott Vascular Inc. Vessel closure devices and methods
US20100185234A1 (en) 2009-01-16 2010-07-22 Abbott Vascular Inc. Closure devices, systems, and methods
US8905937B2 (en) 2009-02-26 2014-12-09 Integrated Vascular Systems, Inc. Methods and apparatus for locating a surface of a body lumen
JP2012523428A (en) * 2009-04-09 2012-10-04 アルカーメス ファーマ アイルランド リミテッド Controlled release Clozapine composition
CH701000A1 (en) * 2009-04-30 2010-11-15 U Nica Technology Ag Bacteriorhodopsin-containing microcapsules and methods for their preparation.
US20110054492A1 (en) 2009-08-26 2011-03-03 Abbott Laboratories Medical device for repairing a fistula
CN102811711A (en) * 2010-03-23 2012-12-05 琳得科株式会社 Solid preparation
US8758399B2 (en) 2010-08-02 2014-06-24 Abbott Cardiovascular Systems, Inc. Expandable bioabsorbable plug apparatus and method
US8603116B2 (en) 2010-08-04 2013-12-10 Abbott Cardiovascular Systems, Inc. Closure device with long tines
PL2637668T3 (en) 2010-11-08 2017-01-31 Albireo Ab Ibat inhibitors for the treatment of liver diseases
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US8821534B2 (en) 2010-12-06 2014-09-02 Integrated Vascular Systems, Inc. Clip applier having improved hemostasis and methods of use
US9149276B2 (en) 2011-03-21 2015-10-06 Abbott Cardiovascular Systems, Inc. Clip and deployment apparatus for tissue closure
WO2013003697A1 (en) 2011-06-30 2013-01-03 Trustees Of Boston University Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
US9332976B2 (en) 2011-11-30 2016-05-10 Abbott Cardiovascular Systems, Inc. Tissue closure device
US9364209B2 (en) 2012-12-21 2016-06-14 Abbott Cardiovascular Systems, Inc. Articulating suturing device
WO2014152338A1 (en) 2013-03-14 2014-09-25 Kabadi Mohan Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
RU2669407C2 (en) 2013-03-15 2018-10-11 ТАРИС Биомедикал ЛЛК Drug delivery devices and methods for drug delivery
JP6041823B2 (en) * 2013-03-16 2016-12-14 ファイザー・インク Oral sustained release dosage form of tofacitinib
US20170172950A1 (en) * 2013-11-13 2017-06-22 National Defense Education And Research Foundation New hepatotoxicity-free pharmaceutical composition containing acetaminophen drugs
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
EP3012252A1 (en) 2014-10-24 2016-04-27 Ferring BV Crystal modifications of elobixibat

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB155898A (en) * 1919-09-22 1920-12-22 Thomas Edwin O Dell Improvements in and connected with tool holders for use on lathes, drilling and similar machines
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
ZA8205384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
JPH0420890B2 (en) * 1981-12-23 1992-04-07 Eisai Co Ltd
JPH0419210B2 (en) * 1982-07-26 1992-03-30 Shinetsu Chem Ind Co
SE457505B (en) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminate coated oral pharmaceutical composition and its foerfarande foer framstaellning
US4627851A (en) * 1984-10-26 1986-12-09 Alza Corporation Colonic-therapeutic delivery system
US4693895A (en) * 1984-10-26 1987-09-15 Alza Corporation Colon delivery system
US4705515A (en) * 1984-10-26 1987-11-10 Alza Corporation Dosage form for administering drug of the colon
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
CH668187A5 (en) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutic system with systemic effect.
US4891223A (en) * 1987-09-03 1990-01-02 Air Products And Chemicals, Inc. Controlled release delivery coating formulation for bioactive substances
US4904474A (en) * 1988-01-25 1990-02-27 Alza Corporation Delivery of drug to colon by oral disage form
US4892739A (en) * 1988-04-25 1990-01-09 Ciba-Geigy Corporation Osmotic continuous dispensing oral delivery system containing a pharmaceutically acceptable active agent having a improved core membrane adhesion properties
IT1230576B (en) * 1988-10-20 1991-10-28 Angeli Inst Spa Pharmaceutical compositions for oral selective release in the colon
DE69011618T2 (en) * 1989-05-11 1994-12-15 Chugai Pharmaceutical Co Ltd Oral formulation for administration to put certain of the intestine.
GB8926639D0 (en) * 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
JPH04346930A (en) * 1991-05-25 1992-12-02 Sumitomo Pharmaceut Co Ltd Stable aspirin enteric tablet
AT195252T (en) * 1993-04-23 2000-08-15 Novartis Erfind Verwalt Gmbh Drug delivery device with controlled release

Also Published As

Publication number Publication date
CY2252B1 (en) 2003-07-04
EP0621032B1 (en) 2000-08-09
AU6050594A (en) 1994-10-27
DK0621032T3 (en) 2000-10-23
US5681584A (en) 1997-10-28
DE69425453T2 (en) 2001-04-12
PT621032E (en) 2001-01-31
JP2006342187A (en) 2006-12-21
CA2121870C (en) 2005-05-17
JP3943144B2 (en) 2007-07-11
CA2121870A1 (en) 1994-10-24
ES2149250T3 (en) 2000-11-01
JPH072648A (en) 1995-01-06
DK621032T3 (en)
IL109338A (en) 1997-11-20
EP0621032A1 (en) 1994-10-26
GR3034571T3 (en) 2001-01-31
DE69425453D1 (en) 2000-09-14
AU687784B2 (en) 1998-03-05
NZ260365A (en) 1994-08-26
IL109338D0 (en) 1994-04-18

Similar Documents

Publication Publication Date Title
DE69630191D1 (en) Pre-filled syringe
DE69212387T2 (en) intravenous device
DK0734233T3 (en) Patient Valet orthopedic device
DE69638364D1 (en) Formulations with controlled delivery (albuterol)
DE69634635D1 (en) Syringe with automatic needle protection
DE69330373D1 (en) syringe
DE69301311D1 (en) Self-agglomerating diketopiperazine-drug delivery system
DE69307109D1 (en) catheter device
FI955259A0 (en) The transdermal therapeutic system containing Estradiol
DE69227882D1 (en) The orthopedic device with more fixed angle
DE69420297T2 (en) dosing syringe
DE69117793T2 (en) Medication infusion system
DE69533551D1 (en) Camptothecin drug combinations with reduced side effects
DE69218013D1 (en) Minimal unflutiges medical device
DE69522550D1 (en) Liquid ophthalmic delivery system with delayed release
DE69625521D1 (en) Quetschabsperrklemmefür an infusion device
DE69428860D1 (en) insulin formulation
DE69327628D1 (en) Transdermal drug administration system
DK0557507T3 (en) injection device
DE69614837D1 (en) Needle-free injection device
DE69022876T2 (en) Drug formulations with delayed release.
DE68928626T2 (en) The implantable infusion device
DE9311907U1 (en) syringe
NO20001227D0 (en) drugs
DE69527509T2 (en) Hydrogel formulation with controlled release

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification